Auro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and approve financial results for the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Auro Laboratories has informed BSE that its Board of Directors will meet on Friday, May 23, 2025. The main agenda is to consider and approve the Audited Financial Results along with the Auditor's Report for the quarter and financial year ended March 31, 2025. The trading window for designated persons and their immediate relatives remains closed until May 25, 2025 (inclusive), in line with insider trading rules. No actual financial numbers have been disclosed in this filing — it is purely a pre-meeting intimation as required by SEBI regulations. The communication is signed by Whole Time Director Siddhartha Deorah.
No immediate impact on shareholders — this is a routine regulatory filing. Investors should watch for the actual FY25 results announcement on or after May 23, 2025, which could move the stock depending on the numbers.